Showing results (41-50 of 79) with videos related to
Sort By:
Pageof 8
Cancer|February 27, 2010
Intra-arterial versus intravenous chemoradiation for advanced head and neck cancer: Results of a randomized phase 3 trialCoen R N Rasch, Michael Hauptmann, Jan Schornagel, et al.Plos One|November 27, 2023
Low dose cisplatin weekly versus high dose cisplatin every three weeks in primary chemoradiotherapy in head and neck cancer patients with low skeletal muscle mass: The CISLOW-study protocolAnouk W M A Schaeffers, Lot A Devriese, Carla H van Gils, et al.British Journal of Clinical Pharmacology|February 24, 2025
Effect of hydration schedules on dose-limiting toxicity in patients with head and neck squamous cell carcinoma treated with cisplatinAnouk W M A Schaeffers, Cassimy B van Neerven, Dorieke van Balen, et al.Molecular Oncology|May 30, 2018
Loss of androgen receptor signaling in prostate cancer-associated fibroblasts (CAFs) promotes CCL2- and CXCL8-mediated cancer cell migrationBianca Cioni, Ekaterina Nevedomskaya, Monique H M Melis, et al.European Journal of Nuclear Medicine and Molecular Imaging|October 28, 2025
[18F]FDG-PET/CT's change in total lesion glycolysis can accurately identify early response upon neoadjuvant immunotherapy prior to curative-intent surgery in cutaneous squamous cell carcinoma; MATISSE trialSabine E Breukers, Robert D Crommelin, Laura A Smit, et al.Plastic and Reconstructive Surgery|April 30, 2019
The Dutch Breast Implant Registry: Registration of Breast Implant-Associated Anaplastic Large Cell Lymphoma-A Proof of ConceptBabette E Becherer, Mintsje de Boer, Pauline E R Spronk, et al.Nuclear Medicine Communications|July 24, 2025
Malignancy classification of thyroid incidentalomas using 18F-fluorodeoxy-d-glucose PET/computed tomography-derived radiomicsMelda Yeghaian, Marceline W Piek, Annemarieke Bartels-Rutten, et al.The Laryngoscope|June 27, 2014
Long-term hearing loss after chemoradiation in patients with head and neck cancerEleonoor A R Theunissen, Charlotte L Zuur, Sophie C J Bosma, et al.Head & Neck|August 3, 2024
The association between skeletal muscle mass and sensorineural hearing loss upon cisplatin-based chemoradiotherapy in patients with head and neck squamous cell carcinomaAnouk W M A Schaeffers, Anouk V M Burger, Charlotte W Duinkerken, et al.Cancer Chemotherapy and Pharmacology|January 17, 2025
Pharmacokinetic exposure and treatment outcomes of lenvatinib in patients with renal cell carcinoma and differentiated thyroid carcinomaMarinda Meertens, Eline L Giraud, Esbar Hassan, et al.Pageof 8